Sergey Semenov

General Director Of TH Biotestlab Ltd. at Biotestlab

Sergii Semenov is currently the Chief Executive Officer at Biotestlab, overseeing the effective operation of the company and team, as well as development and execution of strategic tasks and sales plans in Ukraine and abroad. Prior to this role, Sergii held positions such as Chief Business Development Officer at UMG and Head of Department at Odessa regional state administration, where Sergii focused on project development and investment attraction strategies. With a background in banking and financial management, Sergii has successfully led teams and achieved performance targets throughout their career.

Location

Kyiv, Ukraine

Links


Org chart


Teams

This person is not in any teams


Offices


Biotestlab

BioTestLab is a Ukrainian company. For over 30 years we specialize in the development, production, and sale of veterinary drugs with an individual approach to each client. Our company is in the TOP-20 of the world leaders in the range of vaccines. Creating innovative products for animal and poultry health, thereby improving the impact on human health and the environment, is at the core of our work. Research and innovation are the priority of BioTestLab. We have our own R&D department, and annually register 10+ new unique veterinary products with the introduction to the markets of Ukraine and abroad. In the product range, there are 41 standards and 15+ autogenous vaccines, as well as 65+ chemical-pharmaceuticals for farm animals, poultry, and pets. We manufacture products at our own facilities in Ukraine, equipped with modern equipment. Our company is certified by the world leader — the accreditation agency DQS (Germany) in accordance with the international standard ISO 9001:2015, production processes meet the requirements of GMP (Good Manufacturing Practice). BioTestLab works only with leading manufacturers of active substances and SPF embryos. In the production process, 18 different technologies and 21 pharmaceutical forms (embryonic live and inactivated vaccines, cultural live and inactivated, viral and bacterial, tissue and autogenous, lyophilised, suspension and emulsified, injectable and oral vaccines, injectable and oral antibiotics, antiparasitics, anti-inflammatory, vitamin, mineral drugs, sprays, disinfectants, etc.) are used. As of January 2022, the export geography of BioTestLab products covered 20+ countries.


Headquarters

Kyiv, Ukraine

Employees

201-500

Links